CGS's Hayes on Fukuyama and Furger
If these technologies [such as preimplantation genetic diagnosis, and genetic modification] are embraced by the largely unaccountable infrastructure now being established to support stem cell research, they will be difficult to constrain. Once developed and made commercially available, they would be used disproportionately by the most privileged, and become new and powerful drivers of inequality and exclusion.
The tragedy of this situation is that public opinion surveys consistently show that a strong majority of Americans support a morally serious middle ground regarding the new human genetic technologies.
Hayes concludes that Fukuyama and Furger have responded with "the most comprehensive analysis of human biotech regulatory policy yet published in the United States." Although they may "have missed a beat on just a few topics," the report "should be studied carefully by everyone interested in working towards human biotech policies that can be supported by the great majority of Americans."